Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.059 | 0.8 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |